Search

Your search keyword '"Barbato, E"' showing total 81 results

Search Constraints

Start Over You searched for: Author "Barbato, E" Remove constraint Author: "Barbato, E" Topic business.industry Remove constraint Topic: business.industry
81 results on '"Barbato, E"'

Search Results

1. Williams Syndrome: Oral Findings and Orthodontic Management of a Rare Disease

2. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

3. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

4. Management of myocardial revascularisation failure: an expert consensus document of the EAPCI

5. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

6. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

7. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

8. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

9. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

10. Five-year outcomes with PCI guided by fractional flow reserve

11. Everolimus-eluting stents or bypass surgery for left main coronary artery disease

12. The Frascati Tokamak Upgrade machine: availability analysis, main results and future programme

13. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

14. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

15. Relationship between peripheral arterial reactive hyperemia and the index of myocardial resistance in patients undergoing invasive coronary angiography

16. Heart failure with preserved ejection fraction or non-cardiac dyspnea in paroxysmal atrial fibrillation: The role of left atrial strain

17. Graft patency and progression of coronary artery disease after CABG assessed by angiography-derived fractional flow reserve

18. Insulin Resistance the Hinge Between Hypertension and Type 2 Diabetes

19. Clinical outcomes of PCI with rotational atherectomy: the European multicentre Euro4C registry

20. Assessment of carotid cross-sectional area in hypertensive patients: phenotyping and prognostic validation in The Campania Salute Network

21. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic

22. Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

23. Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy

24. Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention

25. Imaging in ESC clinical guidelines: chronic coronary syndromes

26. Rational and design of the INtentional COronary revascularization versus conservative therapy in patients undergOing successful peripheRAl arTEry revascularization due to critical limb ischemia trial (INCORPORATE trial)

27. Association of improvement in fractional flow reserve with outcomes, including symptomatic relief, after percutaneous coronary intervention

28. Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial

29. Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype A POPular Genetics Subanalysis

30. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

31. Modulation of Insulin Sensitivity by Exercise Training: Implications for Cardiovascular Prevention

32. Global Fractional Flow Reserve Value Predicts 5-Year Outcomes in Patients With Coronary Atherosclerosis But Without Ischemia

33. The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19

34. Effect of Sex on Outcomes of Coronary Rotational Atherectomy Percutaneous Coronary Intervention (From the European Multicenter Euro4C Registry)

35. Motorized fractional flow reserve pullback

36. A personal tribute to Maurizio Galderisi

37. Novel Indices of Coronary Physiology

38. Evaluation of epicardial coronary resistance using computed tomography angiography

39. FFRCT and CT perfusion

40. Double-kissing culotte technique for coronary bifurcation stenting

41. Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial

42. The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction

43. From fallacies to reality: Focus on fractional flow reserve

44. Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment

45. Validation of the all-comers design: Results of the TARGET-AC substudy

46. Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 Years

47. The impact of the extent of side branch disease on outcomes following bifurcation stenting

48. Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial

49. Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: The PROACTIVE trial

50. Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events

Catalog

Books, media, physical & digital resources